BIOSURGERY MARKET ANALYSIS
Global Biosurgery Market: Key Developments
In May 2020, Baxter International Inc. received the U.S. Food and Drug Administration (FDA) approval for Altapore Shape Bioactive Bone Graft, the latest addition to Baxter’s next-generation bone graft substitute product line.
In June 2020, BD completed the acquisition of Straub Medical AG, a privately-held company that develops and sells medical atherectomy and thrombectomy devices.
In September 2019, Integra LifeSciences Holdings acquired Rebound Therapeutics, the developer of single-use medical devices that enable minimally-invasive access by using optics & illumination for visualization, diagnostics, and therapeutic usage in neurosurgery.
In April 2019, Baxter International received its Floseal Hemostatic matrix for use in surgical procedures. The advanced generation Floseal has 20% fewer components and steps of preparation, which makes it easier and faster for use in operating rooms.
Need a Custom Report?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize NowPress Release
Credibility and Certifications
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
U.S.: 
U.K. : 
India :